Veeda Clinical Research Limited

Wishing all our colleagues, clients, friends, and partners a Thanksgiving filled with joy, gratitude, and abundant blessings. May this season bring you happiness, warmth, and the fulfillment of cherished moments with your loved ones! Partners in creating a healthier tomorrow. Heads BIONEEDS INDIA PRIVATE LIMITED #Veeda #VeedaGroup #HappyThanksgiving #Thanksgiving2024

Day 1 of CPHI & PMEC India 2024 witnessed an exciting and interactive conversation between the industry experts and doyens of pharmaceutical industry. Moderating the leadership panel discussion, titled - 𝗖𝗼𝗻𝘁𝗶𝗻𝘂𝗼𝘂𝘀 𝗜𝗻𝗻𝗼𝘃𝗮𝘁𝗶𝗼𝗻 & 𝗔𝗴𝗶𝗹𝗲 𝗠𝗮𝗻𝘂𝗳𝗮𝗰𝘁𝘂𝗿𝗶𝗻𝗴 - Dr. Mahesh Bhalgat, Group CEO & MD of Veeda Clinical Research Limited discussed key trends with eminent industry experts: 1. Atul Shastri, President Operations, Eugia Pharma Specialities Ltd 2. Tathagata Dutta, PhD, President & Chief Technology Officer, Jodas Expoim Pvt. Ltd. 3. Abhay Kumar Srivastava, President Operations, MANKIND PHARMA LTD 4. Prof. V. Ravichandiran, Vice Chancellor, Delhi Pharmaceutical Sciences and Research University (DPSRU), New Delhi and 5. Mr. Yugal Sikri, Managing Director, RPG Life Sciences Ltd. The panel discussion featured conversation on the importance of sustained investment in R&D to drive breakthroughs in therapeutic technologies and the role of partnerships between academia, industry, and government in fostering innovation. Panellists also shared views and case studies on how agile manufacturing allows for rapid scaling of production in response to demand fluctuations and shared examples of how this flexibility has been crucial during public health emergencies, such as the COVID-19 pandemic. The panellist members also expressed views and shared their experiences on the integration of continuous innovation with agile manufacturing to create end-to-end solutions for therapeutic development and touched upon the environmental and economic benefits of combining innovative research with agile manufacturing. https://lnkd.in/gttdupwt #AtTheHeartOfPharma #CPHIAndPMECIndia2024 #PharmaInnovation #AgileManufacturing #LeadershipPanel #FutureOfTherapeutics   CPhI Conferences CPHI Express Pharma BioSpectrum India BioVoice News BioProcess International Contract Pharma Vikas Dandekar ET Pharma

Veeda conducted ISO 17025 training for its employees at biopharma site at Peenya (Bengaluru). Mr. Natarajan G. from ExcelR Solutions conducted the 2-day ISO/IEC 17025:2017 awareness training, which was aimed to enhance understanding of the ISO/IEC 17025:2017 standard that outlines general requirements for the competence of testing and calibration laboratories at Veeda Biopharma. Senior management team members including employees from clinical bioanalysis, analytical and characterization, training and development and quality assurance teams underwent sessions related to Laboratory Management System (LMS) including other core topics of sample management, quality assurance, inventory management, regulatory compliance, legal requirements and collaborations. Dr. Mahesh Bhalgat, Group CEO and MD, also interacted with the participants acknowledging the collaborative effort of all participants showcasing commitment to professional development and enhancement of business performance and continuity. Catch the glimpse of the 2-day training session, conducted by the Training & Development team at Veeda.   Sanjib Banerjee, PhD Jagadeesh Boda, Ph.D. Rajiv Bharadwaj, Ph.D Dr. Swaroop Sarkar Parag K. Patel Sameer pasha Shruthi G S Saumen Saha, Ph.D. Nandan L ASWATHI M VARIER Mithilesh Kumar Dileepkumar P V, PhD Gagana S M Lokesha M M Devangi Dave Rachana Shah HARDIK PATEL BIONEEDS INDIA PRIVATE LIMITED

Veeda’s biopharma site at Peenya (Bengaluru) secures the coveted CDSCO certification from the Directorate General of Health Services, Ministry of Health & Family Welfare, Government of India (GoI). The CDSCO certification to Veeda’s biopharma division is a hallmark of compliance that guarantees high standards of quality in research practices. This regulatory approval establishes Veeda’s authority in maintaining the integrity and safety of the research process, which is essential for producing reliable results. Veeda's Biopharma Division offers a comprehensive range of services to support biotherapeutic drug development. Veeda biopharma’s CDSCO approval has significantly enhanced the credibility of laboratory operations at Peenya (Bengaluru) site. The regulatory approval is a testament of Veeda adhering to stringent quality control measures ensuring that all testing and research activities meet high standards of accuracy and reliability. Veeda’s laboratories follow standardized procedures for testing and analysis, which helps in maintaining consistency and reproducibility of results. The implementation of robust safety protocols at laboratories helps Veeda protect both - the integrity of the samples being tested and the laboratory personnel. The CDSCO certification to biopharma laboratories has also enhanced the credibility of Veeda, making it more attractive to clients and partners, who require assurance of regulatory compliance and high-quality standards. This will propel Veeda to easily participate in national and international research projects and collaborations, expanding its market reach and opportunities.  Veeda offers cutting-edge solutions for clinical bioanalysis that delivers comprehensive bioanalytical services for early and late-phase clinical trials, ensuring accurate and efficient analysis through advanced technology and rigorous quality assurance. Sanjib Banerjee, PhD Sivakumar Vaidyanathan Kiran Marthak Parag K. Patel Heads Amee Kanuga Pranav Dalal Jagadeesh Boda, Ph.D. BIONEEDS INDIA PRIVATE LIMITED Ministry of Health & Family Welfare, Government of India

Join us for an insightful webinar on Advanced Analytical Characterization Techniques for Biopharmaceutical Development: Establishing Biosimilarity! Date: 12 December 2024 Time: 18:30 IST | 14:00 CET | 08:00 EST Our expert speakers, Dr. Nandeesha N P and Dr. Saumen Saha, Ph.D., will delve into key strategies and techniques essential for biosimilar development, from molecular characterization to regulatory approval. Don’t miss this opportunity to learn from real-world case studies and explore emerging technologies in biopharmaceuticals! Key Takeaways: ✅ Biosimilar development & Regulatory insights ✅ HRMS for Molecular Characterization ✅ Higher Order Structure (HOS) Assessment ✅ Overcoming analytical challenges in Complex biopharmaceuticals Register now! https://lnkd.in/dt5Zx2UV Heads BIONEEDS INDIA PRIVATE LIMITED To know more about us, visit www.veedacr.com or write to us at info@veedacr.com. Partners in creating a healthier tomorrow. #Webinar #Biopharmaceuticals #Biosimilars #AnalyticalCharacterization #Biotech #HRMS #PharmaDevelopment #HigherOrderStructure #Biosimilarity #EmergingTechnologies #VeedaGroup #DrugDevelopment #PharmaInnovation #PharmaResearch

Developing highly sensitive assays for complex molecules often presents significant barriers!   Measurement challenges occur because analytes are often present in very low concentrations and complex mixtures with interfering substances. Veeda Group offers extensive expertise in the precise bioanalysis of a wide range of drugs, including: - Peptides - Anticancer drugs - Neurotransmitters - Inhalation drugs - Chemoprotective agents - Lithium - Iron-based drugs   Our established methods achieve sensitivity levels as low as 0.2 pg/mL, ensuring accurate results even for the most challenging analytes. Heads BIONEEDS INDIA PRIVATE LIMITED To know more about us, visit www.veedacr.com or write to us at info@veedacr.com. Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #VeedaCR #Bioanalytical #ComplexMolecules #Peptides #ClinicalResearch #DrugDevelopment

Let’s Connect at ASH 2024!   Veeda Group’s Chief Operating Officer – Global Clinical Trials, Mr. James Brook, will be attending the 66th ASH Annual Meeting from December 7-10, 2024, in San Diego, USA.   Veeda offers a unique proposition – a global, full-service CRO with the added advantage of access to India’s robust research environment and core teams. This combination ensures a seamless balance of recruitment in both Western and Eastern markets, delivering significant cost benefits.   Schedule a Meeting to discuss Veeda Group’s extensive oncology and hematology expertise, spanning from pre-clinical to late-phase solutions.   Book Now: https://lnkd.in/g87SCHPH Heads BIONEEDS INDIA PRIVATE LIMITED To know more about us, visit www.veedacr.com or write to us at info@veedacr.com. Partners in creating a healthier tomorrow. #Veeda #VeedaGroup #VeedaCR #ASHAnnualMeeting #GlobalClinicalTrials #CRO

Join us for an insightful webinar on Advanced Analytical Characterization Techniques for Biopharmaceutical Development: Establishing Biosimilarity! Date: 12 December 2024 Time: 18:30 IST | 14:00 CET | 08:00 EST Our expert speakers, Dr. Nandeesha N P and Dr. Saumen Saha, Ph.D., will delve into key strategies and techniques essential for biosimilar development, from molecular characterization to regulatory approval. Don’t miss this opportunity to learn from real-world case studies and explore emerging technologies in biopharmaceuticals! Key Takeaways: ✅ Biosimilar development & Regulatory insights ✅ HRMS for Molecular Characterization ✅ Higher Order Structure (HOS) Assessment ✅ Overcoming analytical challenges in Complex biopharmaceuticals Register now! https://lnkd.in/dt5Zx2UV Heads BIONEEDS INDIA PRIVATE LIMITED To know more about us, visit www.veedacr.com or write to us at info@veedacr.com. Partners in creating a healthier tomorrow. #Webinar #Biopharmaceuticals #Biosimilars #AnalyticalCharacterization #Biotech #HRMS #PharmaDevelopment #HigherOrderStructure #Biosimilarity #EmergingTechnologies #VeedaGroup #DrugDevelopment #PharmaInnovation #PharmaResearch

Only 30 mins left for our upcoming webinar on Multiple Myeloma: Opportunities and Challenges in the Changing Treatment Landscape!   Date: 15th November, 2024 Time: 6:30pm IST | 3:00pm EET | 8:00am EST Platform: Zoom Hear from Medical Oncologist with over 13 Years of Experience: Veeda Group’s Associate Director and Global Safety Physician, Dr. Stavros Gkolfinopoulos, specializes in solid and hematologic malignancies, clinical trials, drug safety, and risk management Key Highlights of the webinar: · Understand the evolving landscape for treating transplant-eligible and ineligible patients. · New Second-Line Treatment Breakthroughs, including the resurgence of Belantamab Mafodotin. · New Endpoints in the Clinical Trial Design. · Opportunities & Challenges in multiple myeloma drug development Don't miss out— Join now: https://lnkd.in/dWhh28fJ To know more about us, visit www.veedacr.com or write to us at info@veedacr.com. Partners in creating a healthier tomorrow. Heads BIONEEDS INDIA PRIVATE LIMITED #Veeda #VeedaCR #VeedaGroup #Webinar #MultipleMyeloma #LiveNow

Join us at CPHI India 2024 as Veeda Group’s CEO & MD, Dr Mahesh Bhalgat, takes centre stage in two impactful leadership discussions!   On November 26th, 2024, Dr. Mahesh will moderate a high-profile panel at Pharma Connect Congress (11 AM – 12 Noon IST), leading a dialogue on "Continuous Innovation & Agile Manufacturing for the Next Generation Therapeutics."   The discussion will explore: · Dynamic portfolio selection · Driving R&D innovation · Agile manufacturing practices with patient-centricity · AI-powered process development · Sustainability in pharma manufacturing   He will engage with an esteemed panel featuring industry leaders, including Anil Matai (OPPI India), Atul Shastri (Eugia Pharma), Dr. Tathagata Dutta (Jodas Expoim), Abhay Srivastava (Mankind Pharma), and Prof. Ravichandran (NIPER-Kolkata)   Later that afternoon, Dr. Mahesh will join Pharma Leaders' Roundtable (2:30 PM – 4:30 PM), an exclusive CEO roundtable session focused on "Seizing New Frontiers: Unlocking India’s Potential Amidst Global Shifts." This discussion brings together 20-25 senior decision-makers from India’s pharmaceutical sector to explore new opportunities and tackle challenges emerging from evolving global supply chain dynamics and manufacturing trends.   Don’t miss these exciting sessions at the India Expo Centre, Greater Noida, Delhi NCR   To know more write to us at info@veedacr.com or visit us at www.veedacr.com Partners in creating a healthier tomorrow. Heads BIONEEDS INDIA PRIVATE LIMITED #Veeda #VeedaExpert #VeedaCR #ClinicalResearch #IndiaExpoCentre #PharmaConnectCongress